Speaker Profile
Ph.D., Co-Founder & CSO, Generation Lab
Biography
Irina Conboy is a pioneer in the science of aging and rejuvenation. She earned her PhD at Stanford University and spent two decades at UC Berkeley, where her research uncovered fundamental paradigms of systemic aging and mapped the physiologic curve of human biological aging. This work made it possible, for the first time, to quantify (not predict) biological age and disease risk across internal organ systems, and it forms the foundation of Generation Lab’s technology.
She leads the journal Rejuvenation Research, reviews for NIH Study Sections and high-impact journals, and advises Juvena, Immunis, and The Alliance for Longevity Initiative. Her many honors include the California Award in Regenerative Medicine, awards from Calico, Open Philanthropy, and the Sackler, Keck, Ellison, and Glenn foundations, and a National Research Service Award. She holds several US patents, and her highly cited papers are frequently featured in the press.
Talk
First-in-Class Human Rejuvenation Drug Candidate
Generaiton Lab developed a rejuvenation drug candidate, One Generation. Early work shows strong safety and potential against inflammation, fibrosis, oxidative damage, and senescence. It lowered cardiovascular risk markers and cortisol while improving cognition, mood, strength, endurance, weight, and libido, by raising IGF-1 within a healthy youthful range.
Wellness & Aging Showcase:
Generation Lab
Generation Lab is a pioneering longevity biotechnology company translating cutting-edge aging research into actionable health insights. SystemAge Test analyzes 460 biomarkers to measure biological aging across 21 organ systems, empowering individuals to optimize their health and longevity.
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2027 Large Scale Data Solutions Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
